$NEXI

My perception of this company is that it is incredibly oversold and has been walked down for months

Despite no notable debt, they have cash runway for the next year and a half. They will be presenting at Barclays 2022 (03/17/22) & they just announced that they's partnering with The Laura and Isaac Perlmutter Cancer Center for Melanoma research.

Also they appointed Kristi Jones as CEO, who was previously a VP at AstraZeneca (which is up 100% on the 5 Year).